Agman Capital LLC Makes New $3.92 Million Investment in Avantor, Inc. $AVTR

Key Points

• Agman Capital LLC opened a new position in Avantor, buying 341,605 shares worth about $3.92 million in the fourth quarter. The stake represents about 3.3% of Agman’s portfolio.
• Avantor’s latest quarterly results topped expectations, with EPS of $0.17 versus $0.16 expected and revenue of $1.58 billion versus $1.54 billion expected. Analysts still forecast full-year earnings of $0.79 per share.
• Sentiment around the stock remains cautious: several analysts have cut ratings or price targets, and the consensus rating is now “Reduce” with a consensus price target of $10.57. At the same time, two directors recently bought shares, signaling some insider confidence.

Agman Capital LLC purchased a new position in shares of Avantor, Inc. (NYSE:AVTR - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 341,605 shares of the company's stock, valued at approximately $3,915,000. Avantor comprises about 3.3% of Agman Capital LLC's portfolio, making the stock its 13th biggest position. Agman Capital LLC owned about 0.05% of Avantor at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. EverSource Wealth Advisors LLC grew its stake in shares of Avantor by 119.1% in the second quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company's stock valued at $29,000 after buying an additional 1,189 shares in the last quarter. Private Trust Co. NA grew its stake in shares of Avantor by 46.2% in the fourth quarter. Private Trust Co. NA now owns 2,769 shares of the company's stock valued at $32,000 after buying an additional 875 shares in the last quarter. Strategic Wealth Investment Group LLC acquired a new stake in shares of Avantor in the second quarter valued at about $32,000. Los Angeles Capital Management LLC acquired a new stake in shares of Avantor in the fourth quarter valued at about $32,000. Finally, Osaic Holdings Inc. grew its stake in shares of Avantor by 60.9% in the second quarter. Osaic Holdings Inc. now owns 2,810 shares of the company's stock valued at $38,000 after buying an additional 1,064 shares in the last quarter. 95.08% of the stock is currently owned by institutional investors and hedge funds.

Avantor Price Performance

Shares of NYSE AVTR opened at $9.38 on Friday. Avantor, Inc. has a fifty-two week low of $7.26 and a fifty-two week high of $15.93. The business has a 50 day moving average price of $8.38 and a two-hundred day moving average price of $9.63. The company has a quick ratio of 1.17, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. The firm has a market cap of $6.40 billion, a PE ratio of -11.57, a price-to-earnings-growth ratio of 5.45 and a beta of 0.97.

Avantor (NYSE:AVTR - Get Free Report) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $0.17 earnings per share for the quarter, beating analysts' consensus estimates of $0.16 by $0.01. Avantor had a positive return on equity of 9.95% and a negative net margin of 8.42%.The firm had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.54 billion. During the same quarter last year, the firm earned $0.23 EPS. Avantor's quarterly revenue was up .0% on a year-over-year basis. Sell-side analysts expect that Avantor, Inc. will post 0.79 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, Director Simon Dingemans bought 25,000 shares of Avantor stock in a transaction on Friday, May 1st. The shares were bought at an average price of $8.14 per share, with a total value of $203,500.00. Following the acquisition, the director directly owned 25,000 shares in the company, valued at approximately $203,500. This represents a ∞ increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Gregory T. Lucier bought 10,000 shares of Avantor stock in a transaction on Friday, May 8th. The shares were purchased at an average cost of $8.32 per share, for a total transaction of $83,200.00. Following the acquisition, the director owned 60,000 shares in the company, valued at $499,200. The trade was a 20.00% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 0.28% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the company. Barclays lowered their target price on Avantor from $8.50 to $7.00 and set an "underweight" rating for the company in a research note on Tuesday, April 14th. Zacks Research upgraded Avantor from a "strong sell" rating to a "hold" rating in a research note on Thursday, April 30th. Royal Bank Of Canada assumed coverage on Avantor in a research note on Thursday, May 14th. They issued a "sector perform" rating and a $9.00 target price for the company. Wall Street Zen lowered Avantor from a "buy" rating to a "hold" rating in a research note on Saturday, May 30th. Finally, Wolfe Research lowered Avantor to an "underperform" rating and set a $7.00 target price for the company. in a research note on Monday, June 1st. Two analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and three have assigned a Sell rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Reduce" and a consensus price target of $10.57.

Avantor Company Profile

Avantor, Inc NYSE: AVTR is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor's offerings are organized across two primary segments.

Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.